106 related articles for article (PubMed ID: 8237924)
21. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
22. Is there an advantage to be gained from adding digital image cytometry of brush cytology to a standard biopsy protocol in patients with Barrett's esophagus?
Borovicka J; Schönegg R; Hell M; Kradolfer D; Bauerfeind P; Dorta G; Netzer P; Binek J; Meyenberger C; Fischer JE; Spieler P
Endoscopy; 2009 May; 41(5):409-14. PubMed ID: 19418394
[TBL] [Abstract][Full Text] [Related]
23. Another strike against esophagectomy for high-grade dysplasia in Barrett's esophagus?
Wani S; Sharma P
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):128-9. PubMed ID: 18237863
[No Abstract] [Full Text] [Related]
24. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
25. The approach to high grade dysplasia in Barrett's esophagus.
Case CL; Barkin JS
Am J Gastroenterol; 2002 Jun; 97(6):1559-60. PubMed ID: 12094886
[No Abstract] [Full Text] [Related]
26. Anti-reflux surgery is superior to medical management in patients with Barrett's esophagus with low-grade dysplasia.
Chandrasoma P
Am J Gastroenterol; 2007 Sep; 102(9):2111-2. PubMed ID: 17727447
[No Abstract] [Full Text] [Related]
27. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
[TBL] [Abstract][Full Text] [Related]
28. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
29. Partial regression of Barrett's esophagus--an inadequate endpoint.
Sampliner RE; Fass R
Am J Gastroenterol; 1993 Dec; 88(12):2092-4. PubMed ID: 8249978
[TBL] [Abstract][Full Text] [Related]
30. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
[TBL] [Abstract][Full Text] [Related]
31. Histology of metaplasia and dysplasia in Barrett's esophagus.
Yerian L
Surg Oncol Clin N Am; 2009 Jul; 18(3):411-22. PubMed ID: 19500733
[TBL] [Abstract][Full Text] [Related]
32. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
Provenzale D; Schmitt C; Wong JB
Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
[TBL] [Abstract][Full Text] [Related]
33. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia.
Reid BJ; Blount PL; Feng Z; Levine DS
Am J Gastroenterol; 2000 Nov; 95(11):3089-96. PubMed ID: 11095322
[TBL] [Abstract][Full Text] [Related]
34. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
[TBL] [Abstract][Full Text] [Related]
35. Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features.
Gurski RR; Peters JH; Hagen JA; DeMeester SR; Bremner CG; Chandrasoma PT; DeMeester TR
J Am Coll Surg; 2003 May; 196(5):706-12; discussion 712-3. PubMed ID: 12742201
[TBL] [Abstract][Full Text] [Related]
36. Low-grade dysplasia in Barrett's esophagus.
Odze RD; Goldblum JR
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1419-20; author reply 1420. PubMed ID: 17110303
[No Abstract] [Full Text] [Related]
37. [Barrett's esophagus: endoscopic treatment of high-grade dysplasia and early cancer].
Bergman JJ; Marsman WA; Krishnadath KK; Fockens P; van Lanschot JJ; Tytgat GN
Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2275-81. PubMed ID: 14655293
[TBL] [Abstract][Full Text] [Related]
38. Barrett's esophagus with high-grade dysplasia simulating metastatic adenocarcinoma in a fine needle aspiration biopsy.
Gutmann EJ; Suriawinata A; Gordon S
Diagn Cytopathol; 2006 Jul; 34(7):507-10. PubMed ID: 16783781
[TBL] [Abstract][Full Text] [Related]
39. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
Chatelain D; Fléjou JF
Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
[TBL] [Abstract][Full Text] [Related]
40. Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.
Shaheen NJ; Spechler SJ
Endoscopy; 2008 Dec; 40(12):994-9. PubMed ID: 19065482
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]